Literature DB >> 7631391

Multiple or uncommon red cell alloantibodies in women: association with autoimmune disease.

G Ramsey1, S J Smietana.   

Abstract

BACKGROUND: Patients with multiple or uncommon red cell (RBC) alloantibodies require special efforts in the blood bank. This study investigated whether such persons had other immune-related conditions that might help to explain or predict their propensity for RBC antibody formation. STUDY DESIGN AND METHODS: Charts were retrospectively reviewed of 29 men and 83 women with multiple (> or = 3) RBC antibodies of potential clinical significance, uncommon RBC antibodies (anti-e, -Kpb, -Jkb, -Fyb, -S, -U, -Yta, -Dib, -Ata), or both. The clinical features in 43 women with multiple antibodies were compared to those in two equal-sized control cohorts of women matched for transfusion-related diagnoses, but having either one RBC antibody or none.
RESULTS: Women with uncommon RBC antibodies had a 33-percent (18/54) prevalence of autoimmune disease. Twenty-eight percent of the 43 women with multiple antibodies had autoimmune disease, compared to 14 percent of women in the cohort with one RBC antibody (p = 0.09) and 7 percent of those in the cohort without RBC antibodies (p = 0.01). Only one of the 29 men had autoimmune disease.
CONCLUSION: Autoimmune disease is a common underlying factor in women who make multiple or uncommon RBC alloantibodies of potential clinical significance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631391     DOI: 10.1046/j.1537-2995.1995.35795357881.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  16 in total

1.  Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Authors:  David R Gibb; Jingchun Liu; Prabitha Natarajan; Manjula Santhanakrishnan; David J Madrid; Stephanie C Eisenbarth; James C Zimring; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

2.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

3.  B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.

Authors:  David R Gibb; Jingchun Liu; Manjula Santhanakrishnan; Prabitha Natarajan; David J Madrid; Seema Patel; Stephanie C Eisenbarth; Christopher A Tormey; Sean R Stowell; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

4.  Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease.

Authors:  Raisa Balbuena-Merle; Susanna A Curtis; Lesley Devine; David R Gibb; Matthew S Karafin; Chance John Luckey; Christopher A Tormey; Alexa J Siddon; John D Roberts; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-07-29       Impact factor: 3.157

5.  Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.

Authors:  Matthew S Karafin; Matt Westlake; Ronald G Hauser; Christopher A Tormey; Philip J Norris; Nareg H Roubinian; Yanyun Wu; Darrell J Triulzi; Steve Kleinman; Jeanne E Hendrickson
Journal:  Br J Haematol       Date:  2018-04-19       Impact factor: 6.998

Review 6.  The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders.

Authors:  Eric A Gehrie; Christopher A Tormey
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

Review 7.  Understanding red blood cell alloimmunization triggers.

Authors:  Jeanne E Hendrickson; Christopher A Tormey
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization.

Authors:  Alex B Ryder; Jeanne E Hendrickson; Christopher A Tormey
Journal:  Br J Haematol       Date:  2015-10-12       Impact factor: 6.998

9.  Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.

Authors:  David J Madrid; Manjula Santhanakrishnan; Jingchun Liu; David R Gibb; Dong Liu; Prabitha Natarajan; Daniel Beitler; Zhimin Shi; Chunyan Mo; Christopher A Tormey; Seema R Patel; Sean R Stowell; Jeanne E Hendrickson
Journal:  Blood Transfus       Date:  2018-11-07       Impact factor: 5.752

10.  The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice.

Authors:  David R Gibb; Samuele Calabro; Dong Liu; Christopher A Tormey; Steven L Spitalnik; James C Zimring; Jeanne E Hendrickson; Eldad A Hod; Stephanie C Eisenbarth
Journal:  EBioMedicine       Date:  2016-06-16       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.